HSBC Holdings
TVTX icon

HSBC Holdings’s Travere Therapeutics TVTX Stock Holding History

HSBC Holdings’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Buy
+396,853
New +$11.9M 0.01% 888
2025
Q3 		– Sell
-13,308
Closed -$199K – 3142
2025
Q2 		$199K Sell
13,308
-17,429
-57% -$289K ﹤0.01% 2683
2025
Q1 		$542K Buy
30,737
+2,902
+10% +$58.9K ﹤0.01% 2033
2024
Q4 		$487K Sell
27,835
-13,981
-33% -$247K ﹤0.01% 2196
2024
Q3 		$579K Sell
41,816
-7,178
-15% -$74.8K ﹤0.01% 1932
2024
Q2 		$397K Sell
48,994
-4,482
-8% -$30.2K ﹤0.01% 2110
2024
Q1 		$412K Buy
53,476
+3,836
+8% +$32.4K ﹤0.01% 2201
2023
Q4 		$450K Buy
49,640
+5,763
+13% +$42K ﹤0.01% 2092
2023
Q3 		$404K Buy
43,877
+22,106
+102% +$312K ﹤0.01% 2070
2023
Q2 		$337K Buy
21,771
+6,770
+45% +$123K ﹤0.01% 2103
2023
Q1 		$338K Buy
15,001
+3,080
+26% +$65.5K ﹤0.01% 2183
2022
Q4 		$248K Buy
+11,921
New +$253K ﹤0.01% 2668
2021
Q1 		– Sell
-12,778
Closed -$347K – 3138
2020
Q4 		$347K Buy
+12,778
New +$298K ﹤0.01% 2474
2020
Q3 		– Sell
-12,453
Closed -$254K – 2866
2020
Q2 		$254K Sell
12,453
-2,131
-15% -$33.9K ﹤0.01% 2217
2020
Q1 		$209K Sell
14,584
-3,206
-18% -$48.2K ﹤0.01% 2269
2019
Q4 		$254K Buy
+17,790
New +$227K ﹤0.01% 2679

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HSBC Holdings's TVTX Position: Q1 2026 in Review

HSBC Holdings opened a new position in Travere Therapeutics (TVTX) in Q1 2026: 396,853 shares worth $11.8M. The stake represents 0.01% of the portfolio and ranks #888 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in TVTX as recently as Q2 2025.

HSBC Holdings first reported a position in TVTX in Q4 2019 and has held it in 16 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • HSBC Holdings held 396,853 shares of Travere Therapeutics worth $11.8M as of Q1 2026.
  • Travere Therapeutics was a new HSBC Holdings position in Q1 2026.
  • Travere Therapeutics made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #888 holding.
  • HSBC Holdings first reported a position in Travere Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.